General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a no smoking signJanuary 3 2017

Free printed, digital and social resources are now available via Public Health England’s Campaign Resource Centre to help health professionals encourage smokers to quit.

The new campaign materials include posters tailored for different health care settings, and toolkits with packs of materials ready-made for use. In addition to ordering via the CRC, the pharmacy toolkit is available through the pharmacy order line on 0300 123 1019, said PHE.

Digital and social resources include:

  • leaderboard digital banner (customisable versions available);
  • MPU digital banner (customisable versions available);
  • skyscraper digital banner (customisable versions available);
  • email signature;
  • digital TV screen;
  • organic Twitter and Facebook posts, with suggested copy (customisable versions available);
  • paid (sponsored) Twitter and Facebook posts;
  • gifs – a 15sec and 5sec version (download).

This year’s Smokefree Health Harms campaign features a new television advert, highlighting the dangers of tar in cigarettes. It shows how poisons from tar enter the bloodstream, spreading around the body within seconds and causing damage to major organs.

There’s also a PR video, featuring Dr Dawn Harper and Dragon's Den investor Hilary Devey, showing what happens to blood when smoking tobacco. This can be viewed on the NHS Smokefree YouTube channel.

Links:

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...